Literature DB >> 22373644

The search for sensitive biomarkers in presymptomatic Huntington disease.

Pierre-Gilles Henry1, Fanny Mochel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22373644      PMCID： PMC3345907          DOI： 10.1038/jcbfm.2012.17

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN： 0271-678X            Impact factor:   6.200


× No keyword cloud information.
  9 in total

1.  Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.

Authors:  Sarah J Tabrizi; Ralf Reilmann; Raymund A C Roos; Alexandra Durr; Blair Leavitt; Gail Owen; Rebecca Jones; Hans Johnson; David Craufurd; Stephen L Hicks; Christopher Kennard; Bernhard Landwehrmeyer; Julie C Stout; Beth Borowsky; Rachael I Scahill; Chris Frost; Douglas R Langbehn
Journal:  Lancet Neurol       Date:  2011-12-02       Impact factor: 44.182

2.  pH as a biomarker of neurodegeneration in Huntington's disease: a translational rodent-human MRS study.

Authors:  Myriam M Chaumeil; Julien Valette; Céline Baligand; Emmanuel Brouillet; Philippe Hantraye; Gilles Bloch; Véronique Gaura; Amandine Rialland; Pierre Krystkowiak; Christophe Verny; Philippe Damier; Philippe Remy; Anne-Catherine Bachoud-Levi; Pierre Carlier; Vincent Lebon
Journal:  J Cereb Blood Flow Metab       Date:  2012-02-29       Impact factor: 6.200

Review 3.  Huntington's disease.

Authors:  Marianne J U Novak; Sarah J Tabrizi
Journal:  BMJ       Date:  2010-06-30

4.  Challenges assessing clinical endpoints in early Huntington disease.

Authors:  Jane S Paulsen; Chiachi Wang; Kevin Duff; Roger Barker; Martha Nance; Leigh Beglinger; David Moser; Janet K Williams; Sheila Simpson; Douglas Langbehn; Daniel P van Kammen
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

Review 5.  Energy deficit in Huntington disease: why it matters.

Authors:  Fanny Mochel; Ronald G Haller
Journal:  J Clin Invest       Date:  2011-02-01       Impact factor: 14.808

Review 6.  Pathophysiology of Huntington's disease: from huntingtin functions to potential treatments.

Authors:  Emmanuel Roze; Frédéric Saudou; Jocelyne Caboche
Journal:  Curr Opin Neurol       Date:  2008-08       Impact factor: 5.710

7.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Authors: 
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

8.  Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease.

Authors:  A Sturrock; C Laule; J Decolongon; R Dar Santos; A J Coleman; S Creighton; N Bechtel; R Reilmann; M R Hayden; S J Tabrizi; A L Mackay; B R Leavitt
Journal:  Neurology       Date:  2010-11-09       Impact factor: 9.910

9.  Exploratory 7-Tesla magnetic resonance spectroscopy in Huntington's disease provides in vivo evidence for impaired energy metabolism.

Authors:  Simon J A van den Bogaard; Eve M Dumas; Wouter M Teeuwisse; Hermien E Kan; Andrew Webb; Raymund A C Roos; Jeroen van der Grond
Journal:  J Neurol       Date:  2011-05-26       Impact factor: 4.849
  9 in total
  4 in total

1.  Neurochemical correlates of caudate atrophy in Huntington's disease.

Authors:  Jeannie M Padowski; Kurt E Weaver; Todd L Richards; Mercy Y Laurino; Ali Samii; Elizabeth H Aylward; Kevin E Conley
Journal:  Mov Disord       Date:  2014-01-17       Impact factor: 10.338

2.  Laser Evoked Potentials in Early and Presymptomatic Huntington's Disease.

Authors:  Marina de Tommaso; Giovanni Franco; Katia Ricci; Anna Montemurno; Vittorio Sciruicchio
Journal:  Behav Neurol       Date:  2016-03-21       Impact factor: 3.342

3.  EEG Functional Connectivity and Cognitive Variables in Premanifest and Manifest Huntington's Disease: EEG Low-Resolution Brain Electromagnetic Tomography (LORETA) Study.

Authors:  Marianna Delussi; Virgilio Nazzaro; Katia Ricci; Marina de Tommaso
Journal:  Front Physiol       Date:  2020-12-17       Impact factor: 4.566

Review 4.  Metabolomics in plants and humans: applications in the prevention and diagnosis of diseases.

Authors:  Diego F Gomez-Casati; Maria I Zanor; María V Busi
Journal:  Biomed Res Int       Date:  2013-08-06       Impact factor: 3.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.